Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIOTRONIKS-Safety and Performance in de Novo Lesion of Native Coronary Arteries With Magmaris (BIOSOLVE)-IV Magmaris Swiss Satellite Registry

NCT04025788 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT04025788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04025788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIOTRONIKS-Safety and Performance in de Novo Lesion of Native Coronary Arteries With Magmaris (BIOSOLVE)-IV Magmaris Swiss Satellite Registry
Lead sponsor
University Hospital, Geneva
Phase
Observational
Overall status
Terminated
Start date
March 26, 2019
Completion date
January 1, 2022
Enrollment
10 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease